Providence Saint Joseph Among the First to Implant Miniature Wireless Cardiac Monitor
April 30, 2014
REVEAL LINQ™ ICM Provides Long-Term Remote Monitoring to Help Physicians Diagnose and Monitor Irregular Heartbeats
BURBANK (April 29, 2014) -- Providence Saint Joseph Medical Center today became one of the first hospitals in Southern California to implant patients with the Medtronic Reveal LINQ Insertable Cardiac Monitor System, the smallest implantable cardiac monitoring device available.
The Reveal LINQ ICM is approximately one-third the size of an AAA battery, making it more than 80 percent smaller than other implanted monitors. While significantly smaller, the device is part of a powerful system that allows physicians to continuously and wirelessly monitor a patient’s heart for up to three years, with 20 percent more data memory than its larger predecessor, Reveal® XT.
Providence Saint Joseph Patient Elizabeth Wolf, 79, of Ojai, who had suffered a stroke, was excited to benefit from the latest heart monitoring technology. She expected to be home within a few hours and travel next month to England for the birth of a grandchild.
Cardiologist David Mok, M.D., said the procedure went very well. He said the monitor would indicate whether Wolf suffered atrial fibrillation, a type of abnormal heart rhythm that would put her at greater risk of another stroke.
“The monitor is state-of-the-art; it’s a simple procedure, which is a significant benefit to the patient,” he said. “She’ll be able to go home in a few hours.” Dr. Mok implanted the miniature monitor in a second patient a short time later.
In addition to its continuous and wireless monitoring capabilities, the system provides remote monitoring through the Carelink® Network, which can alert physicians their patients have had cardiac events. The Reveal LINQ ICM is indicated for patients who experience symptoms such as dizziness, palpitation, fainting and chest pain that may suggest a cardiac arrhythmia, and for patients at increased risk for arrhythmias.
Placed just beneath the skin through a ¼-inch incision in the upper left side of the chest, the Reveal LINQ ICM is often nearly invisible to the naked eye once inserted. The device is placed using a minimally invasive insertion procedure, which simplifies the experience for both physicians and their patients. The Reveal LINQ ICM is MR-Conditional, allowing patients to undergo magnetic resonance imaging (MRI) if needed.
The Reveal LINQ system also includes the new MyCareLink ™ Patient Monitor, a simplified remote monitoring system with global cellular technology that transmits patients’ cardiac device diagnostic data to their clinicians from nearly any location in the world.